Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Does CG0070 have better efficacy than Ruvidar PDT?

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Jan 29, 2024 10:58am

178 Views

Post# 35850367

RE:RE:RE:RE:RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?

I suggest that the people sitting at home with bladders intact, having not suffered the life altering effects of genetically forced medical mutation to their immune system courtesy of drugs like Keytruda. May disagree with the term Mickey Mouse when referring to TLD1433 and the development of an effective ACT by Theralase. Once this next hurdle of BTD is cleared I guess we shall see.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec